Clinical end scientific utility of engineered tissues critically depends on our ability to direct and modulate cell differentiation and functional tissue assembly, in vitro and in vivo. The focus of this core will be on the development and utilization of novel bioreactors designed to precisely control the cellular microenvironment, impart multiple physical stimuli, and enable real time imaging of cells and tissues at various hierarchical scales. Osteochondral (cartilage/bone) tissues and myocardium are selected as paradigms of distinctly different, clinically relevant engineered tissues to serve as models for bioreactor development and validation. Two different bioreactor systems will be established: one with mechanical stimulation (for engineering osteochondral tissues) and one with electrical stimulation (for engineering myocardium). We envision three interrelated areas of research in this core: 1. Engineered constructs will be used as controllable tissue models for studies of cell responses to genetic and environmental factors using nondestructive imaging methods (fluorescence microscopy, frequency-domain optical imaging, MRI, ultrasound and mu CT). 2. The obtained information will drive the development of """"""""biomimetic"""""""" protocols for functional tissue engineering. 3. The progression of tissue assembly and the functionality of engineered constructs will be analyzed in vitro and in animal models. Mathematical models developed in our previous studies will be further extended to analyze the kinetic and transport rates and establish correlations between the environmental factors, structural and functional tissue properties. Overall, Core 3 has been designed to form the basis for answering fundamental biological questions in controlled studies of cartilage, bone and myocardium.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Biotechnology Resource Grants (P41)
Project #
1P41EB002520-01A1
Application #
6956182
Study Section
Special Emphasis Panel (ZRG1-BST-D (40))
Project Start
2004-08-15
Project End
2009-07-31
Budget Start
2004-08-15
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$349,494
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
073134835
City
Medford
State
MA
Country
United States
Zip Code
02155
Huang, Wenwen; Ling, Shengjie; Li, Chunmei et al. (2018) Silkworm silk-based materials and devices generated using bio-nanotechnology. Chem Soc Rev 47:6486-6504
Ronaldson-Bouchard, Kacey; Ma, Stephen P; Yeager, Keith et al. (2018) Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556:239-243
Marturano-Kruik, Alessandro; Nava, Michele Maria; Yeager, Keith et al. (2018) Human bone perivascular niche-on-a-chip for studying metastatic colonization. Proc Natl Acad Sci U S A 115:1256-1261
Algarrahi, Khalid; Affas, Saif; Sack, Bryan S et al. (2018) Repair of injured urethras with silk fibroin scaffolds in a rabbit model of onlay urethroplasty. J Surg Res 229:192-199
Algarrahi, Khalid; Franck, Debra; Savarino, Alyssa et al. (2018) Bilayer silk fibroin grafts support functional oesophageal repair in a rodent model of caustic injury. J Tissue Eng Regen Med 12:e1068-e1075
Chen, Timothy; Vunjak-Novakovic, Gordana (2018) In vitro Models of Ischemia-Reperfusion Injury. Regen Eng Transl Med 4:142-153
Wobma, Holly M; Tamargo, Manuel A; Goeta, Shahar et al. (2018) The influence of hypoxia and IFN-? on the proteome and metabolome of therapeutic mesenchymal stem cells. Biomaterials 167:226-234
Ling, Shengjie; Wang, Qi; Zhang, Dong et al. (2018) Integration of stiff graphene and tough silk for the design and fabrication of versatile electronic materials. Adv Funct Mater 28:
Dinjaski, Nina; Huang, Wenwen; Kaplan, David L (2018) Recursive Directional Ligation Approach for Cloning Recombinant Spider Silks. Methods Mol Biol 1777:181-192
Liu, Bohao; Lee, Benjamin W; Nakanishi, Koki et al. (2018) Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng 2:293-303

Showing the most recent 10 out of 610 publications